Logos Capital
San Francisco, California, United States · Series A → Series B
Their stated focus (public profile)
Logos Capital is a biotechnology-focused investment fund dedicated to advancing healthcare through disciplined, data-driven investing. The fund targets transformative, first-in-class, and best-in-class companies in the biotechnology sector across both private and public markets. Their process integrates rigorous clinical underwriting, continuous event tracking, and proactive risk management. Their proprietary platform, Logos Analytics, supports investment decisions through modeling and analysis of clinical data.
Stages: Series A → Series B
Sectors: Life sciences, Healthtech
Website: logoscapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.